Santhera Pharmaceuticals (0QN1.LSE) Q3 2025 Earnings

23SepConfirmed
Q2 2024
Q3 2024
Q2 2025
Q3 2025
-3.03
-2.45
-1.86
-1.28

Details

Expected EPS
N/A
Actual EPS
-3.03249416704
Surprise EPS
-3.03
Surprise Percent
+∞%

Description

Santhera Pharmaceuticals (0QN1.LSE) has reported earnings of -3.03249416704 per share for Q3 2025.

0 Comments

Share your thoughts